Cytodyn Correlations

CYDY Stock  USD 0.14  0.00  0.00%   
The current 90-days correlation between Cytodyn and Scpharmaceuticals is -0.12 (i.e., Good diversification). The correlation of Cytodyn is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Cytodyn Correlation With Market

Good diversification

The correlation between Cytodyn and DJI is -0.11 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cytodyn and DJI in the same portfolio, assuming nothing else is changed.
The ability to find closely correlated positions to Cytodyn could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytodyn when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytodyn - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytodyn to buy it.

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
High negative correlations   

Risk-Adjusted Indicators

There is a big difference between Cytodyn OTC Stock performing well and Cytodyn OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cytodyn's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ICPT  2.96 (0.74) 0.00  1.17  0.00 
MDGL  2.56  0.49  0.15 (3.30) 2.55 
SCPH  3.50  0.10  0.03  0.14  4.56 
AKRO  2.90  0.36  0.12  0.35  2.96 
ARAV  3.52 (0.29) 0.00 (0.11) 0.00 
CRDF  3.25 (0.96) 0.00 (0.68) 0.00 
RVPH  4.47 (1.11) 0.00  0.74  0.00 
EFTR  7.57 (4.54) 0.00  10.90  0.00 
PDSB  3.72  0.52  0.13  0.36  4.06 
NAVB  6.04 (1.15) 0.00 (1.66) 0.00 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Cytodyn without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run ETFs Now



Find actively traded Exchange Traded Funds (ETF) from around the world
All  Next Launch Module

Cytodyn Corporate Management

Elected by the shareholders, the Cytodyn's board of directors comprises two types of representatives: Cytodyn inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cytodyn. The board's role is to monitor Cytodyn's management team and ensure that shareholders' interests are well served. Cytodyn's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cytodyn's outside directors are responsible for providing unbiased perspectives on the board's policies.